DOSE.CN
Price:
$0.23
Market Cap:
$29.79M
Rapid Dose Therapeutics Corp., a life sciences company, provides drug delivery technologies designed to enhance outcomes and quality of lives in Canada. The company offers QuickStrip/PharmaStrip, an oral fast-dissolving drug delivery system to rapidly release active ingredients into the blood stream, such as pharmaceuticals, emulsified oils, and over-the-counter medicines; QuickStrip energy to deliver energizing caffeine; QuickStrip B12 to deliver vitamin B12 in the system; and QuickStrip sleep that delivers melatonin in the system. The company also provides product innovation, production, and consultation services to the nutraceutical, cannabis healthcare, and pharmaceutical manufacturing i...[Read more]
Industry
Biotechnology
IPO Date
2010-02-10
Stock Exchange
CNQ
Ticker
DOSE.CN
According to Rapid Dose Therapeutics Corp.’s latest financial reports and current stock price. The company's current ROE is 132.04%. This represents a change of 297.44% compared to the average of 33.22% of the last 4 quarters.
The mean historical ROE of Rapid Dose Therapeutics Corp. over the last ten years is 295.46%. The current 132.04% ROE has changed -55.31% with respect to the historical average. Over the past ten years (40 quarters), DOSE.CN's ROE was at its highest in in the February 2020 quarter at 657.04%. The ROE was at its lowest in in the February 2022 quarter at -2899.50%.
Average
295.46%
Median
132.08%
Minimum
-3373.73%
Maximum
5.39%
Discovering the peaks and valleys of Rapid Dose Therapeutics Corp. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 206.70%
Maximum Annual ROE = 5.39%
Minimum Annual Increase = -3057.14%
Minimum Annual ROE = -3373.73%
Year | ROE | Change |
---|---|---|
2025 | 103.82% | -23.86% |
2024 | 136.35% | -4.44% |
2023 | 142.69% | -104.23% |
2022 | -3373.73% | -3057.14% |
2021 | 114.09% | -97.88% |
2020 | 5.39% | -1909.94% |
2019 | -297.78% | -175.96% |
2017 | 392.01% | 206.70% |
2016 | 127.81% | -41.83% |
2015 | 219.71% | 128.92% |
The current ROE of Rapid Dose Therapeutics Corp. (DOSE.CN) is less than than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
127.62%
5-year avg
-575.36%
10-year avg
295.46%
Rapid Dose Therapeutics Corp.’s ROE is
Company | ROE | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Rapid Dose Therapeutics Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Rapid Dose Therapeutics Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Rapid Dose Therapeutics Corp.'s ROE?
How is the ROE calculated for Rapid Dose Therapeutics Corp. (DOSE.CN)?
What is the highest ROE for Rapid Dose Therapeutics Corp. (DOSE.CN)?
What is the 3-year average ROE for Rapid Dose Therapeutics Corp. (DOSE.CN)?
What is the 5-year average ROE for Rapid Dose Therapeutics Corp. (DOSE.CN)?
How does the current ROE for Rapid Dose Therapeutics Corp. (DOSE.CN) compare to its historical average?